Clicky

Amgen Inc.(AMG) News

Date Title
Jul 3 Amgen (AMGN) Announces Full Results from Part 1 of the Phase 2 study of MariTide
Jul 2 Amgen (AMGN) Outperforms Broader Market: What You Need to Know
Jul 2 mAbxience Announces European Commission Approval of Denosumab Biosimilars
Jul 2 This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk
Jul 1 Trading Rotation Kicks Off 2nd Half of 2025
Jul 1 Amgen and Zai Lab’s trial of gastric cancer therapy meets primary endpoint
Jun 30 Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
Jun 30 AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR BEMARITUZUMAB IN FIBROBLAST GROWTH FACTOR RECEPTOR 2b (FGFR2b) POSITIVE FIRST-LINE GASTRIC CANCER
Jun 30 2 Dividend Stocks to Buy on the Dip and Hold Forever
Jun 28 Jim Cramer Says That Amgen’s Stock “Did Not Deserve to Get Hit This Hard”
Jun 27 Amgen Looks to Take Share of Booming Obesity Space: Will It Succeed?
Jun 27 Here's Why Amgen (AMGN) is a Strong Growth Stock
Jun 27 Cancer Vaccine (Preventative, Therapeutic) Market Research 2025 with Analyst Recommendations-Leveraging AI and Bioinformatics for Precision Development / Pursue Fast-Track and Orphan Drug Designations
Jun 13 BMY Focuses on Label Expansion of Drugs: Will This Revive Growth?
Jun 13 Amgen (NASDAQ:AMGN) Has A Pretty Healthy Balance Sheet
Jun 13 AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY
Jun 12 Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider
Jun 10 Why Amgen (AMGN) is a Top Growth Stock for the Long-Term
Jun 9 Why Amgen (AMGN) is a Top Value Stock for the Long-Term
Jun 9 3 Generic Drug Stocks to Watch Amid Pricing Pressure & Tariff Threats